NVRO Nevro Corp

Nevro Corp develops and sells medical devices mainly in the United States. Its main product is the Senza system which is intended to relieve leg and spinal cord pain with the application of the HF10 therapy.

$92.80  +5.50 (6.30%)
As of 12/06/2021 16:00:01 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  USA
IPO date:  11/06/2014
Outstanding shares:  34,904,128
Average volume:  748,884
Market cap:   $3,187,444,969
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    64157F103
ISIN:        US64157F1030
Sedol:      BS7K7C9
Valuation   (See tab for details)
PE ratio:   -28.12
PB ratio:   9.54
PS ratio:   8.09
Return on equity:   -33.95%
Net income %:   -27.51%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy